Back

High-sensitivity c-reactive protein to high-density lipoprotein cholesterol ratio and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

28 August 2023 (15:15 - 15:45)
Organised by: Logo
Congress Presentation Part of: Interventional cardiology and biomarkers Coronary Angiography ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Jin Liu

Guangdong Provincial People's Hospital, Guangzhou (China)

4 More presentations in this session

Presentation thumbnail
Circulating intermediate monocytes increase after elective percutaneous coronary intervention
Doctor U. Bhalraam (Norfolk, GB)
Abstract Slides Video
Presentation thumbnail
Mortality after periprocedural myocardial injury and spontaneous myocardial infarction according to the levels of troponin increase: insights from a large PCI registry
Doctor A. Spirito (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography
Doctor E. Steinacher (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
C-reactive protein levels and coronary in-stent restenosis: A systematic review and meta-analysis
Doctor H. Rai (Dublin 7, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional cardiology and biomarkers

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction
thumbnail
Congress Presentation
Clinical impact of systemic inflammation across the spectrum of different high-sensitivity CRP values in patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Contrast volume to creatinine clearance ratio, a strong predictor of contrast induced nephropathy in patients undergoing percutaneous intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources